The IN VIVO Blog Podcast: All M&A Edition

Tune in to this week's podcast by clicking on the logo below. What's in store for you? Last week it was all-FDA. This week, it's all-M&A.

Roger and Chris co-opt Mike and Ramsey's three-things format and courageously brush aside cough and cold symptoms to discuss the merits of Merck/Schering-Plough, comment on some of the scuttlebutt surrounding Nycomed and Allergan, and speculate about what the increase in earn-outs and options-to-acquire means for small biotechs and their VC investors.

Oh and there's a plug for the Canada Dry-flavored Halls throat lozenges in there too. Don't ever say we don't tip you off to the exciting things in life.

Don't forget, you can access the podcast via iTunes also.